![]() Castle Creek Biosciences Castle Creek Biosciences (also known as Castle Creek Pharma) is a company that develops and commercializes gene therapies for patients with rare and serious genetic diseases. | ![]() Aegicare Aegicare is a company that specializes in genetic intelligence to enable precise medical diagnosis and drug research and development. | ![]() CAMP4 Therapeutics CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression. | ![]() Oxford BioTherapeutics Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs. | ||
Founding Date | Founding Date N/A | Founding Date 2017 | Founding Date 2016 | Founding Date 2016 | Founding Date 2004 |
Type | Type Private | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Exton, US HQ | Locations Shenzhen, CN HQ Palo Alto, US | Locations Cambridge, US HQ | Locations Babraham, GB HQ Histon, GB | Locations Milton, GB HQ San Jose, US |
Employees | Employees 3613% increase | Employees 6 | Employees 66 | Employees 1644% decrease | Employees 504% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) £2.1m (FY, 2018) |
Net income | Net income N/A | Net income N/A | Net income ($80.4m) (FY, 2025) | Net income N/A | Net income (£6.5m) (FY, 2018) |
Funding | |||||
Latest funding round | Latest funding round $ 55m (about 6 years ago) | Latest funding round $ 4m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 41.5m (almost 6 years ago) | Latest funding round $ 10m (almost 11 years ago) |
Total funding raised | Total funding raised $ 174.8m | Total funding raised $ 7.8m | Total funding raised $ 30m | Total funding raised $ 41.5m | Total funding raised $ 21.6m |

Aegicare is a company that specializes in genetic intelligence to enable precise medical diagnosis and drug research and development.
View company
CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression.
View company
Bit Bio is a company that develops a cell reprogramming platform.
View company
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
View company